Literature DB >> 26551571

Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland.

Tomasz M Karpiński1, Ewa Andrzejewska1, Piotr Eder2, Krzysztof Linke2, Andrzej Szkaradkiewicz1.   

Abstract

Increasing resistance to drugs represents a serious problem in treatment of infections with Helicobacter pylori, providing cause of frequent therapeutic failures. Present study aimed at analysis of changes in resistance of H. pylori to antibiotics in West Poland within the recent 15 years. 108 strains of H. pylori were analysed, isolated from gastric mucosa of adult patients. Group 1 involved 66 strains isolated in years of 1998/1999. Group 2 comprised 42 isolates obtained in years of 2013/2014. Susceptibility to amoxicillin (AMX), clarithromycin (CL), tetracycline (TC) and metronidazole (MTZ) was determined by E-test (AB Biodisc). All strains on both studied groups were susceptible to AMX. In group 1 all strains proved to be susceptible to TC, while 9% and 36% of tested strains were resistant to CL and MTZ, respectively. By contrast, in group 2, 31% and 83% of strains were resistant to CL and MTZ, respectively. In parallel, 14% strains were found to be resistant to TC (according to EUCAST interpretations). In West Poland, within recent 15 years a dramatic increase was noted in H. pylori strains resistant to metronidazole. In parallel, a significant increase was noted in proportion of strains resistant to clarithromycin.

Entities:  

Keywords:  Helicobacter pylori; antibiotic resistance; chronic gastritis; peptic ulcer disease; treatment

Mesh:

Substances:

Year:  2015        PMID: 26551571     DOI: 10.1556/030.62.2015.3.6

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  2 in total

Review 1.  Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.

Authors:  Yi Hu; Yin Zhu; Nong-Hua Lu
Journal:  Front Cell Infect Microbiol       Date:  2017-05-05       Impact factor: 5.293

2.  Antibiotic resistance of Helicobacter pylori isolated from patients in Nanjing, China: A cross-section study from 2018 to 2021.

Authors:  Zongdan Jiang; Xuetian Qian; Zhi Wang; Yunfan Dong; Yuqin Pan; Zhenyu Zhang; Shukui Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-09-08       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.